World's Best Scientists 2026 revealed!
Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
126
Citations
58285
World Ranking
2963
National Ranking
55

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Bo Ahrén is affiliated with Lund University in Sweden and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research primarily focuses on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Pharmacology, and Physiology.

Their work covers a range of topics including:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Pharmacology and Obesity Treatment
  • Diet and metabolism studies
  • Muscle metabolism and nutrition

Bo Ahrén has published in several scientific venues, with frequent publications in:

  • Journal of Diabetes Investigation
  • Frontiers in Endocrinology
  • Peptides
  • Biomedicines
  • Diabetologia

Recent publications by Bo Ahrén include:

  • Glucose effectiveness: Lessons from studies on insulin-independent glucose clearance in mice, 2020, Journal of Diabetes Investigation
  • The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice, 2021, Frontiers in Endocrinology

Other selected recent papers related to their research but authored primarily by collaborators include:

  • Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy, 2023, Diabetologia
  • Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test, 2021, Frontiers in Endocrinology
  • Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: Characteristics and regulation, 2022, Journal of Diabetes Investigation

Frequent collaborators with whom Bo Ahrén has co-authored multiple publications include:

  • Giovanni Pacini
  • Christian Göbl
  • Andrea Tura
  • Micaela Morettini
  • Ian J. Neeland

Best Publications

  • Interleukin-6-deficient mice develop mature-onset obesity.

    Ville Wallenius;Kristina Wallenius;Bo Ahrén;Mats Rudling

  • The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.

    Maria Sörhede Winzell;Bo Ahrén

  • Autonomic regulation of islet hormone secretion--implications for health and disease.

    B. Ahrén

  • Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.

    M Gutniak;C Orskov;J J Holst;B Ahrén

  • Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetes

    Bo Ahrén;Mona Landin-Olsson;Per Anders Jansson;Maria Svensson

  • Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease

    Thomas Nyström;Mark K. Gutniak;Qimin Zhang;Fan Zhang

  • Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes.

    Bo Ahrén;Ramon Gomis;Eberhard Standl;David Mills

  • Islet Amyloid and Type 2 Diabetes Mellitus

    Jo W.M. Höppener;Bo Ahrén;Cornelis J.M. Lips

  • FOXC2 Is a Winged Helix Gene that Counteracts Obesity, Hypertriglyceridemia, and Diet-Induced Insulin Resistance

    Anna Cederberg;Line M. Grønning;Bo Ahrén;Kjetil Taskén

  • Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.

    Bo Ahrén;Erik Simonsson;Hillevi Larsson;Mona Landin-Olsson

  • Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes

    Bo Ahrén

  • Leptin is associated with increased risk of myocardial infarction.

    Stefan Söderberg;B Ahrén;J H Jansson;Owe Johnson

  • Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver

    G. Bryzgalova;H. Gao;B. Ahren;J. R. Zierath

  • Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.

    Bo Ahrén;Giovanni Pacini;James E. Foley;Anja Schweizer

  • Dose-dependent inhibition by ghrelin of insulin secretion in the mouse.

    Martina Kvist Reimer;Giovanni Pacini;Bo Ahrén

  • Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study

    Tommy Jönsson;Yvonne Granfeldt;Bo Ahrén;Ulla-Carin Branell

  • Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting

    Bo Ahrén;Sven Månsson;Ronald L. Gingerich;Peter J Havel

  • Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial

    Bo Ahrén;Luis Masmiquel;Harish Kumar;Mehmet Sargin

  • Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

    E. Ferrannini;V. Fonseca;B. Zinman;D. Matthews

  • Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion.

    B. Ahrén;G. J. Taborsky;G. J. Taborsky;D. Porte;D. Porte

Frequent Co-Authors

Frank Sundler
Frank Sundler Lund University
Giovanni Pacini
Giovanni Pacini National Research Council (CNR)
Jens J. Holst
Jens J. Holst University of Copenhagen
Hindrik Mulder
Hindrik Mulder Lund University
Tommy Olsson
Tommy Olsson Umeå University
Suad Efendic
Suad Efendic Karolinska Institute
Carolyn F. Deacon
Carolyn F. Deacon University of Copenhagen
Stefan Söderberg
Stefan Söderberg Umeå University
Peter J. Havel
Peter J. Havel University of California, Davis
Cecilia Holm
Cecilia Holm Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring pathways beyond the traditional MD, there are several flexible online options that complement a career in medicine or healthcare. For those interested in management roles, healthcare administration programs can lead to leadership positions in hospitals, clinics, and other health organizations.

Nurses who already have an associate degree can advance their careers and clinical skills by enrolling in adn to fnp programs, which offer a bridge to becoming a Family Nurse Practitioner.

A growing emphasis on preventive care has also created opportunities in nutrition. Earning a nutrition bachelor degree online is an excellent choice for those interested in dietetics, health coaching, or public health education.

For aspiring healthcare executives, top cahme-accredited mha programs provide advanced training in health administration with recognized accreditation, boosting both credibility and career opportunities.

These online degrees offer flexibility and career mobility, making them ideal for working professionals or students seeking diverse roles in the dynamic world of healthcare.

Best Scientists Citing Bo Ahrén

Trending Scientists

Recently Published Articles